dermatology

News in brief: Novel combination biologics for recalcitrant psoriasis; Hand sanitisers may contain contact allergens; Specialty training colleges’ ‘dirty secret’

Novel combination biologics for recalcitrant psoriasis Dual biologic therapy may be an effective option for patients with recalcitrant psoriasis that is not controlled by biologic monotherapy or other agents, Sydney dermatologists say. A novel combination of an IL-23 inhibitor (risankizumab) with a TNF-inhibitor (golimumab) was successful in the treatment of a 49-year old man with ...

Already a member?

Login to keep reading.


OR
© 2022 the limbic